We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Intl.Medical | LSE:INT | London | Ordinary Share | GB00B035PZ17 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.83 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
01/5/2008 00:24 | Well all the trades at 1.35 are buys as one of them was mine.Once this seller is finished then there will be a great re-rating of the stock. | tinker tailor | |
30/4/2008 19:10 | cyberpost, post 600 - I agree with what you're saying. It's just that seeing the share price continually go down makes me feel something isn't quite right. we'll see in about 3 weeks. I notice that they've put the BAUS annual meeting on the calendar. If the share price goes down much further I think I'll be attending the Tuesday plenary session. Hope I don't ever have to know anything regards the Monday session. :) | ged5 | |
30/4/2008 16:51 | This is the type of opportunity where the normal private investor can make serious returns on their investment. | tornadodown | |
30/4/2008 16:27 | looks like a distressed seller. wants out at any price. | cyberpost | |
30/4/2008 16:25 | At least the drop has sparked off some buying rather than more selling. | rokkie | |
30/4/2008 16:15 | I am at a loss at who is selling at this price. Why bother ? | cyberpost | |
30/4/2008 15:53 | Well 1.35p offer is available but it's not pretty online as there's 750k up for grabs but at least the mm's is offering a much fairer price for it than 1.6p. | 8trader | |
30/4/2008 15:30 | Must have something to do with a old acquisition paid for in stock and lots of it, i remember reading it somewhere and deduced that it must be them happy to sell at any price, even silly ones like the 1.1p we've just seen ! | 8trader | |
29/4/2008 16:11 | Ged if there was a change in trading which was materially different from forecasts then they would have been obliged to issue an RNS. The fact that no trading statement was made either way (before close period), implies trading is inline with expectation which means its profitable. Its the lack of substantive news for such a long period that is hitting the share price. Bored investors selling, and with no buyers the market makers drop down the price. I am sure once the results are announced the price will bounce back very strongly. | cyberpost | |
29/4/2008 15:17 | Greedy mm's though ! You'd think they would offer stock at say 1.3p and give pi's a chance of a rare opportunity to average down at a nice price but they keep the offer at 1.6p approx. | 8trader | |
29/4/2008 13:55 | Did Chris Thomas have a notifiable holding at any time? Just thought it might be him selling. With directors buying recently at 4p and debt seemingly manageable these sales look like madness. With net assets of 19.7M turnover of 11.2M and making profits we're undervalued at 3-4p so what's going on. They haven't been telling "porkies" have they? | ged5 | |
29/4/2008 12:34 | cant understand why people are selling at such a big discount. must be very desperate. | cyberpost | |
23/4/2008 14:45 | Well thats me fully loaded on this one now brought another 100k. Good luck all. | martincoops | |
23/4/2008 14:03 | has anybody seen how MLH has recently taken off and gone skywards...there are certain similarities to this share except the actual figures appear to be better from INT. Not researched it in any detail so don't shoot me if I am wrong! Any opinion on which way it is going to go?? seems logical it will head north based on the facts, but then it keeps stepping downwards bit by bit!! Also not much discussion on this thread and not many pi's interested in it! | nils214 | |
23/4/2008 12:56 | RBCRBC - 23 May | rokkie | |
23/4/2008 11:47 | When are the results out ? | rbcrbc | |
23/4/2008 08:55 | Well in for another 50k lets hope the results are positive and the forward looking statement is encouraging. | martincoops | |
23/4/2008 08:46 | "The sales from the retractable safety needle (in the NHS catalouge) will start to filter through" Have we had any evidence of sales yet. That would be the biggest positive news. | ged5 | |
23/4/2008 08:10 | BUY BUY BUY BUY BUY BUY BUY BUY BUY BUY BUY BUY Will that do? | james t kirk | |
22/4/2008 13:01 | this price is a screaming bargin. why? -The company has started to make a profit -The sales from the retractable safety needle (in the NHS catalouge) will start to filter through -the potential of near future dividends -the sales of and potential inogen one anybody want to add to my positivism? | tricky1992000 | |
16/4/2008 19:38 | Pity INT didn't have a distribution agreement in Australia. However the Inogen One may take off in Europe. There's a little bit on page 2 about a competitor device as well. "A medical gadget called the Inogen ONE is a "breakthrough" portable oxygen generator that concentrates oxygen, doing away with cumbersome liquid oxygen tanks and restoring quality of life to the ultimate form of organic technology: human beings... ...So there are a range of medical conditions and at least a million Australians who could benefit from a new medical gadget called the Inogen ONE. It won't synchronise with Windows, it's not iPhone compatible, it definitely doesn't have a Wi-Fi connection and you can forget about USB ports. What it does is to interface directly with the human body, bypassing all forms of computing technology, to deliver life-giving oxygen to the lungs, bloodstream, body and even our own CPU: the brain. Cumbersome liquid oxygen tanks can now be a thing of the past, with the Inogen ONE a sleek back pack size portable oxygen generator, weighing just 4.4kg, giving millions of COPD affected people worldwide a new lease of life, even letting them travel freely on planes, with the FAA approving its use in 38 airlines, including Qantas. The Inogen ONE recently won the prestigious U.S. Medical Design Excellence Award, with judges calling it "a groundbreaking innovation changing the face of health care". " Just a reminder about the Inogen One distribution agreement | ged5 | |
16/4/2008 17:37 | Nils, The main point I was trying to make is that AIM stocks often overreact to news good or bad, and tend to drift down when there is no news. Especially overreacting to T1psters and BB comments. Slow and steady growth tends not to get noticed. INT has issued no recent news about contract wins IIRC. | rbcrbc | |
15/4/2008 11:51 | JTK, the way I see it is that the growth is forecast as being 'steady' rather than spectacular over the next 2-3 years, and I guess it is this as much as anything which is weighing heavily on the share price (plus the debt and the conversion of debt into shares as mentioned above). Possibly only when the debt is converted and the real value is recognised will the share price truly reflect the NAV imho | nils214 | |
15/4/2008 11:46 | GED, thanks for the reply. I went through the accounts to end 2007 and I noticed that the figure of 17% is quoted in their and I guess this takes into account the additional debt already. One other question, there seems to be a lot of debt that is convertible into shares, has anybody worked out the dilutive effects of this when it happens and how this will/might affect the SP?? | nils214 | |
15/4/2008 10:43 | Most AIM stocks were pulled lower over the last few months, where no news was immenent as I believe MM's expected shares to be sold because of the change in CGT relief. However little INT shares were sold but price was dropped way out of proportion and I see this as a fantastic time to buy into a company which has proven it can make a profit and should grow nicely over next few years. | james t kirk |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions